These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 8584113)

  • 21. Localization and characterization of vasopressin binding sites in the rat brain using an iodinated linear AVP antagonist.
    Johnson AE; Audigier S; Rossi F; Jard S; Tribollet E; Barberis C
    Brain Res; 1993 Sep; 622(1-2):9-16. PubMed ID: 8242389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Similarities between hamster pancreatic islet beta (HIT) cell vasopressin receptors and V1b receptors.
    Richardson SB; Laya T; VanOoy M
    J Endocrinol; 1995 Oct; 147(1):59-65. PubMed ID: 7490538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach.
    Oshikawa S; Tanoue A; Koshimizu TA; Kitagawa Y; Tsujimoto G
    Mol Pharmacol; 2004 Mar; 65(3):623-9. PubMed ID: 14978240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescent pseudo-peptide linear vasopressin antagonists: design, synthesis, and applications.
    Durroux T; Peter M; Turcatti G; Chollet A; Balestre MN; Barberis C; Seyer R
    J Med Chem; 1999 Apr; 42(7):1312-9. PubMed ID: 10197974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist.
    Tahara A; Saito M; Sugimoto T; Tomura Y; Wada K; Kusayama T; Tsukada J; Ishii N; Yatsu T; Uchida W; Tanaka A
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):63-9. PubMed ID: 9459574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of potent and selective linear antagonists of vasopressor (V1-receptor) responses to vasopressin.
    Manning M; Stoev S; Kolodziejczyk A; Klis WA; Kruszynski M; Misicka A; Olma A; Wo NC; Sawyer WH
    J Med Chem; 1990 Nov; 33(11):3079-86. PubMed ID: 2231609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasopressin-binding sites in the pig pituitary gland: competition by novel vasopressin antagonists suggests the existence of an unusual receptor subtype in the anterior lobe.
    Arsenijevic Y; Dubois-Dauphin M; Tribollet E; Manning M; Sawyer WH; Dreifuss JJ
    J Endocrinol; 1994 Jun; 141(3):383-91. PubMed ID: 8071638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A V1-type receptor for mediating the neurohypophysial hormone-induced ACTH release in trout pituitary.
    Pierson PM; Guibbolini ME; Lahlou B
    J Endocrinol; 1996 Apr; 149(1):109-15. PubMed ID: 8676042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G
    Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subcellular localization and internalization of the vasopressin V1B receptor.
    Kashiwazaki A; Fujiwara Y; Tsuchiya H; Sakai N; Shibata K; Koshimizu TA
    Eur J Pharmacol; 2015 Oct; 765():291-9. PubMed ID: 26318147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of AVP and oxytocin on insulin release: involvement of V1b receptors.
    Lee B; Yang C; Chen TH; al-Azawi N; Hsu WH
    Am J Physiol; 1995 Dec; 269(6 Pt 1):E1095-100. PubMed ID: 8572202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery and design of novel and selective vasopressin and oxytocin agonists and antagonists: the role of bioassays.
    Chan WY; Wo NC; Stoev ST; Cheng LL; Manning M
    Exp Physiol; 2000 Mar; 85 Spec No():7S-18S. PubMed ID: 10795902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrapituitary expression of the rat V1b vasopressin receptor gene.
    Lolait SJ; O'Carroll AM; Mahan LC; Felder CC; Button DC; Young WS; Mezey E; Brownstein MJ
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6783-7. PubMed ID: 7624319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isosteric substitution of Asn5 in antagonists of oxytocin and vasopressin leads to highly selective and potent oxytocin and V1a receptor antagonists: new approaches for the design of potential tocolytics for preterm labor.
    Chan WY; Wo NC; Cheng LL; Manning M
    J Pharmacol Exp Ther; 1996 May; 277(2):999-1003. PubMed ID: 8627583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological profile of YM087, a novel potent nonpeptide vasopressin V1A and V2 receptor antagonist, in vitro and in vivo.
    Tahara A; Tomura Y; Wada KI; Kusayama T; Tsukada J; Takanashi M; Yatsu T; Uchida W; Tanaka A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):301-8. PubMed ID: 9223568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel ligand specificity of pituitary vasopressin receptors in the rat.
    Antoni FA
    Neuroendocrinology; 1984 Aug; 39(2):186-8. PubMed ID: 6089020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frog glomerular vasotocin receptors resemble mammalian V1b receptors.
    Ammar A; Rajerison RM; Roseau S; Bloch-Faure M; Butlen D
    Am J Physiol; 1994 Nov; 267(5 Pt 2):R1198-208. PubMed ID: 7977846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasopressin and oxytocin receptors coupled to Ca2+ mobilization in rat inner medullary collecting duct.
    Maeda Y; Han JS; Gibson CC; Knepper MA
    Am J Physiol; 1993 Jul; 265(1 Pt 2):F15-25. PubMed ID: 8393622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of [3H] SR 49059, a potent nonpeptide vasopressin V1a antagonist, to rat and human liver membranes.
    Serradeil-Le Gal C; Raufaste D; Marty E; Garcia C; Maffrand JP; Le Fur G
    Biochem Biophys Res Commun; 1994 Feb; 199(1):353-60. PubMed ID: 8123034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxytocin-induced contractions within rat and rabbit ejaculatory tissues are mediated by vasopressin V1A receptors and not oxytocin receptors.
    Gupta J; Russell R; Wayman C; Hurley D; Jackson V
    Br J Pharmacol; 2008 Sep; 155(1):118-26. PubMed ID: 18552879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.